Max Scherzer’s next move is still on the table, and the answer won’t come until the offseason.
The Blue Jays right-hander will take the ball Sunday in the season finale against the Reds, but he said he’s not ready to decide whether this is the end of a 19-year career. Scherzer also noted that his family will be at the game, in case it turns out to be his final start.
That uncertainty fits the moment. Scherzer turned 42 last July, and while he was more definitive about wanting to come back after Toronto’s Game 7 loss in the World Series last year, this season has pushed the conversation in a different direction.
The Blue Jays slipped to a losing record in 2026, Scherzer dealt with another injury-filled campaign, and the looming lockout is weighing heavily on his thinking. He told The Athletic’s Brittany Ghiroli and Mitch Bannon earlier this week that it is “ a big part of the calculus ” for him.
That lockout could disrupt the normal offseason routine and might even put 2027 regular-season games in jeopardy. Scherzer has spent plenty of time in MLBPA leadership over the years, but with that uncertainty hanging over the sport, retirement may feel more appealing than another round of unknowns.
On the field, the decline has been hard to ignore. Scherzer’s 2022 season with the Mets was the last time he looked close to peak form, when he put up a 2.29 ERA across 145 1/3 innings. In 2023, he logged a 3.77 ERA over 152 2/3 combined innings with the Mets and Rangers, and he was better after the trade to Texas, helping the Rangers win their first championship.
Since then, injuries have taken a real toll. Scherzer has been limited to 206 regular-season innings since that 2023 season, plus 14 1/3 innings in Toronto’s postseason run last fall.
He still posted a 3.77 ERA in those playoffs, but the regular season has been rougher: a 5.19 ERA in 85 innings in 2025, followed by a 6.14 ERA in 77 2/3 innings this year, with Sunday’s outing still to come. His 18.1% strikeout rate and 10.1% walk rate in 2026 are both career worsts, and he has had trouble keeping the ball in the park during his two seasons with the Blue Jays.
Toronto originally signed Scherzer to a one-year, $15.5MM deal in the 2024-25 offseason, then brought him back for 2026 on another one-year contract with just $3MM guaranteed. He has already picked up $2MM in bonuses, and he can add another $1MM if he reaches 7 1/3 innings on Sunday.
If he does return for another season, the next deal is likely to look similar: short-term, incentive-heavy, and tied to a contender. A return to the Blue Jays is still possible, too, since the club values his presence in the room and could use all the pitching depth it can find after the injuries that hit the staff this year.
Whenever Scherzer does call it a career, the Hall of Fame case won’t require much debate. He’ll be a first-ballot inductee five years after retirement, with three Cy Young Awards, eight All-Star selections, World Series titles with Washington and Texas, 224 wins, and 3,550 strikeouts. That strikeout total ranks ninth all-time, just four behind Justin Verlander for eighth, and with Verlander set for the final start of his career today, Scherzer may have a number in sight heading into Sunday.
In Other News...
Rangers Suddenly Face Another Josh Jung Injury Fear
Josh Jungs latest injury scare has landed the Rangers right back in familiar territory. After returning from a calf strain and giving the lineup a much-needed boost, Jung was hit by a pitch against the Twins and suffered a right hand fracture, the same hand he broke earlier this season.
Further testing is planned to determine how serious the damage is, but the timing alone is a brutal blow for Texas. Jung had been performing well since coming back, and now the Rangers may be looking at the possibility that his season is over just as he had started to settle in again. [Read more 🡒]
Rangers May Have Found A 2027 Pitching Fix Fans Didn't Expect
Skip Schumaker has spent the 2026 season squeezing extra value out of the Rangers starting pitchers by dropping them into long relief roles, a wrinkle that already produced Jordan Montgomerys first career save. It is the kind of pitching usage that can look strange at first glance, but it has given Texas a way to stabilize innings while keeping arms available in a staff that has had to adapt on the fly.
The idea is not entirely new, either. It mirrors the way the Miami Marlins have used starters as swingmen under Clayton McCullough, and it is the sort of flexible approach that could matter even more for Texas as free agency and roster turnover loom. If the Rangers keep leaning into this model, they may have stumbled onto a practical answer for how to cover innings without overtaxing the bullpen, even if the long-term shape of the staff still needs to be sorted out. [Read more 🡒]
Nathan Eovaldi Now Carries Texas Into A Season-Defining Start
Nathan Eovaldi is moving back into a familiar role for the Rangers at a critical moment, with Texas announcing that he will start Saturday against the Minnesota Twins. Since returning from the injured list, Eovaldi has been working out of the bullpen rather than taking the ball to open games, so this marks a notable shift as the Rangers try to steady themselves down the stretch.
Texas is counting on Eovaldi to help keep its playoff pursuit on track while it battles the Houston Astros for the AL West title. The timing gives this start extra weight, since the Rangers are not simply looking for innings, they are looking for answers, and Eovaldi now becomes part of a stretch that could shape how the division race finishes. [Read more 🡒]